ShanXi C&Y Pharmaceutical Group Co., Ltd. (300254.SZ) SHZ

10.39

+0.22(+2.16%)

Updated at December 30 03:04PM

Currency In CNY

Valuation

Market Cap2.18B
Enterprise Value2.34B
P/E Ratio124.14
PEG Ratio0.95
Price/Sales Ratio2.97
Price/Book Ratio8.59
Enterprise/Revenue3.59
Enterprise/EBITDA28.77

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.02
Operating Margin0.09

Management Effectiveness

Return On Assets0.01
Return On Equity0.07

Income Statement

Revenue846.61M
Revenue/Share3.48
Gross Profit566.45M
EBITDA156.01M
Net Income42.19M
Diluted EPS0.17

Balance Sheet

Total Cash128.98M
Total Cash/Share0.53
Total Debt652.05M
Total Debt/Equity2.22
Current Ratio0.92
Book Value Per Share2.37

Price History

52-Week Change16.74
52-Week High14.23
52-Week Low7.44
Moving Average 50 Days10.6
Moving Average 200 Days10.46

Statistics

Average Volume7.01M
Shares Outstanding242.02M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.66
Last Split Factor6:5
Last Split DateJuly 08, 2016